Milk From Women Diagnosed With COVID-19 Does Not Contain SARS-CoV-2 RNA but Has Persistent Levels of SARS-CoV-2-Specific IgA Antibodies.
Milk From Women Diagnosed With COVID-19 Does Not Contain SARS-CoV-2 RNA but Has Persistent Levels of SARS-CoV-2-Specific IgA Antibodies.
复制标题
DOI:
10.3389/fimmu.2021.801797
复制
发表时间:
2021
影响因子:
7.3
通讯作者:
Seppo AE
中科院分区:
文献类型:
--
作者:
Pace RM;Williams JE;Järvinen KM;Meehan CL;Martin MA;Ley SH;Barbosa-Leiker C;Andres A;Yeruva L;Belfort MB;Caffé B;Navarrete AD;Lackey KA;Pace CDW;Gogel AC;Fehrenkamp BD;Klein M;Young BE;Rosen-Carole C;Diaz N;Gaw SL;Flaherman V;McGuire MA;McGuire MK;Seppo AE
Limited data are available regarding the balance of risks and benefits from human milk and/or breastfeeding during and following maternal infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To investigate whether SARS-CoV-2 can be detected in milk and on the breast after maternal coronavirus disease 2019 (COVID-19) diagnosis; and characterize concentrations of milk immunoglobulin (Ig) A specific to the SARS-CoV-2 spike glycoprotein receptor binding domain (RBD) during the 2 months after onset of symptoms or positive diagnostic test. Using a longitudinal study design, we collected milk and breast skin swabs one to seven times from 64 lactating women with COVID-19 over a 2-month period, beginning as early as the week of diagnosis. Milk and breast swabs were analyzed for SARS-CoV-2 RNA, and milk was tested for anti-RBD IgA. SARS-CoV-2 was not detected in any milk sample or on 71% of breast swabs. Twenty-seven out of 29 (93%) breast swabs collected after breast washing tested negative for SARS-CoV-2. Detection of SARS-CoV-2 on the breast was associated with maternal coughing and other household COVID-19. Most (75%; 95% CI, 70-79%; n=316) milk samples contained anti-RBD IgA, and concentrations increased (P=.02) during the first two weeks following onset of COVID-19 symptoms or positive test. Milk-borne anti-RBD IgA persisted for at least two months in 77% of women. Milk produced by women with COVID-19 does not contain SARS-CoV-2 and is likely a lasting source of passive immunity via anti-RBD IgA. These results support recommendations encouraging lactating women to continue breastfeeding during and after COVID-19 illness.
登录
查看更多内容
DOI:
10.1111/cea.12228
发表时间:
2014-01
期刊:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
影响因子:
--
作者:
Järvinen KM;Westfall JE;Seppo MS;James AK;Tsuang AJ;Feustel PJ;Sampson HA;Berin C
通讯作者:
Berin C
影响因子:
5.8
作者:
Fox A;Marino J;Amanat F;Krammer F;Hahn-Holbrook J;Zolla-Pazner S;Powell RL
通讯作者:
Powell RL
影响因子:
2
作者:
Congdon JL;Kair LR;Flaherman VJ;Wood KE;LoFrumento MA;Nwaobasi-Iwuh E;Phillipi CA;Better Outcomes through Research for Newborns (BORN) Network
通讯作者:
Better Outcomes through Research for Newborns (BORN) Network
影响因子:
168.9
作者:
Chen, Huijun;Guo, Juanjuan;Zhang, Yuanzhen
通讯作者:
Zhang, Yuanzhen
影响因子:
26.1
作者:
Ronchi, Andrea;Pietrasanta, Carlo;Pugni, Lorenza
通讯作者:
Pugni, Lorenza